Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
HealthTree Resources
Posted by 
Last updated and reviewed on: January 05, 2025We invite you to read the sources below to learn more about CLL therapies.
HealthTree News Articles and Pages
- CLL Genetic Features
- “Off-the-Shelf" CAR T-Cell Therapy for CLL
- Relapsed/Refractory CLL Treatment Options
- What is Sonrotoclax for CLL?
- Zanubrutinib + Venetoclax for High-Risk First-Time Treated CLL
- Years on, Ibrutinib + Venetoclax Keeps High-Risk CLL in Remission
- What If Venetoclax Stops Working?
- Venetoclax for CLL: Treatment Options and Patient Outcomes
- What are BTK Inhibitors for CLL?
- Bispecific Antibodies for CLL Webinar
- New CLL Medicines in Clinical Trials: BTK Degraders
- Making the Choice in CLL: Acalabrutinib or Zanubrutinib
- First-Time Treated CLL? Learn About the New Combination of Pirtobrutinib + Obinutuzumab
- First-Ever FDA-Approved CAR T-Cell Therapy for R/R CLL: Liso-cel (Breyanzi)
- Do CLL Patients Prefer Fixed-Duration or Continuous-Duration Therapy?
HealthTree University Videos
- When should a patient start their treatment for CLL?
- What treatment options are available for patients with CLL?
- What is the goal of therapy for CLL?
- How are treatment plans developed for patients with CLL?
- What CLL patients need treatment right away?
- What symptoms may indicate the need to start treatment?
- What Types of Treatment Options are Available for CLL Patients?
- What types of conversations should patients have with their doctors?
- What are some of the major side effects of treatment that patients should be prepared for?
- If I don't see any side effects from my medication, does that mean it isn't working?
- How can I prepare for the end of treatment, both emotionally and practically?
- Clinical Trials & Experimental Treatments: Opportunities for Patients
- Are there any clinical trials or experimental treatments patients may be eligible for
- Is fixed-duration therapy or continuous-duration therapy the best option for a patient?
- All about BTK Inhibitors
- All About Venetoclax
HealthTree Webinars
- What are the Current CLL Clinical Trials? With Ryan Jacobs, MD
- How Are CLL Medicines' Side Effects Managed? with Deborah Stephens, DO
- Relapsed/Refractory CLL Treatment Options with Dr. Kerry Rogers
- Fixed-Duration vs. Continuous-Duration CLL Medicines with Dr. Alvaro Alencar
- All About Bispecific Antibodies for CLL with Dr. Adam Kittai
- A Personalized CLL Vaccine: NeoVax with Inhye Ahn, MD Dana-Farber Cancer Institute
- How Can CLL Clinical Trials Help Me? Learn from Dr. Danielle Brander of Duke Cancer Institute
- Finding Financial Support and Resources for Your CLL Treatment
- Infection Prevention for CLL Patients with Dr. Meghan Thompson